Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roel Coutinho

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Addiction (Abingdon, England)|August 19, 2007
Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug usersCharlotte Van Den Berg, Colette Smit, Giel Van Brussel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 29, 2008
Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective studyColette Smit, Charlotte van den Berg, Ronald Geskus, et al.
Sexually Transmitted Infections|July 2, 2013
Hepatitis B vaccination of men who have sex with men in the Netherlands: should we vaccinate more men, younger men or high-risk men?Maria Xiridou, Robin van Houdt, Susan Hahné, et al.
AIDS (London, England)|March 4, 2006
Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversionColette Smit, Ronald Geskus, Sarah Walker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2005
Expression of chemokine receptors CCR5 and CXCR4 on CD4+ T cells and plasma chemokine levels during treatment of active tuberculosis in HIV-1-coinfected patientsDawit Wolday, Belete Tegbaru, Afework Kassu, et al.
AIDS (London, England)|January 27, 2009
Steep declines in population-level AIDS mortality following the introduction of antiretroviral therapy in Addis Ababa, EthiopiaGeorges Reniers, Tekebash Araya, Gail Davey, et al.
Ethiopian Medical Journal|July 2, 2004
Development of research capability in Ethiopia: the Ethio-Netherlands AIDS research project (ENARP): 1994-2002, achievements, scientific findings and project goalsEduard J Sanders, Tsehaynesh Messele, Dawit Wolday, et al.
Addiction (Abingdon, England)|September 17, 2011
The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in AmsterdamAmy Matser, Anouk Urbanus, Ronald Geskus, et al.
Tropical Medicine & International Health : TM & IH|January 20, 2004
Lay diagnosis of causes of death for monitoring AIDS mortality in Addis Ababa, EthiopiaTekebash Araya, Georges Reniers, Ab Schaap, et al.
Social Science & Medicine (1982)|June 2, 2005
Monitoring cause-specific adult mortality in developing countries: a comparison of data sources for Addis Ababa and its implications for policy and researchGeorges Reniers, Tekebash Araya, Ab Schaap, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Addiction (Abingdon, England)|August 19, 2007
Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug usersCharlotte Van Den Berg, Colette Smit, Giel Van Brussel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 29, 2008
Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective studyColette Smit, Charlotte van den Berg, Ronald Geskus, et al.
Sexually Transmitted Infections|July 2, 2013
Hepatitis B vaccination of men who have sex with men in the Netherlands: should we vaccinate more men, younger men or high-risk men?Maria Xiridou, Robin van Houdt, Susan Hahné, et al.
AIDS (London, England)|March 4, 2006
Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversionColette Smit, Ronald Geskus, Sarah Walker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2005
Expression of chemokine receptors CCR5 and CXCR4 on CD4+ T cells and plasma chemokine levels during treatment of active tuberculosis in HIV-1-coinfected patientsDawit Wolday, Belete Tegbaru, Afework Kassu, et al.
AIDS (London, England)|January 27, 2009
Steep declines in population-level AIDS mortality following the introduction of antiretroviral therapy in Addis Ababa, EthiopiaGeorges Reniers, Tekebash Araya, Gail Davey, et al.
Ethiopian Medical Journal|July 2, 2004
Development of research capability in Ethiopia: the Ethio-Netherlands AIDS research project (ENARP): 1994-2002, achievements, scientific findings and project goalsEduard J Sanders, Tsehaynesh Messele, Dawit Wolday, et al.
Addiction (Abingdon, England)|September 17, 2011
The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in AmsterdamAmy Matser, Anouk Urbanus, Ronald Geskus, et al.
Tropical Medicine & International Health : TM & IH|January 20, 2004
Lay diagnosis of causes of death for monitoring AIDS mortality in Addis Ababa, EthiopiaTekebash Araya, Georges Reniers, Ab Schaap, et al.
Social Science & Medicine (1982)|June 2, 2005
Monitoring cause-specific adult mortality in developing countries: a comparison of data sources for Addis Ababa and its implications for policy and researchGeorges Reniers, Tekebash Araya, Ab Schaap, et al.
Pageof 4